Prof Jonathan Ledermann at ESMO 2014: Inhibiting PARP, angiogenesis and immune checkpoints for treating ovarian cancer

At the European Society for Medical Oncology (ESMO) 2014 Congress, Prof Jonathan Ledermann (University College London, UK) discusses recent advances in the management of ovarian cancer, including the ... Author: EMJ Added: 03/05/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts